Relationship between progression of visual field defect and intraocular pressure in primary open-angle glaucoma

To analyze the relationship between intraocular pressure (IOP) and the progression of visual field defects in Japanese primary open-angle glaucoma (POAG) and normal-tension glaucoma (NTG) patients. The subjects of the study were patients undergoing treatment for POAG or NTG who had performed visual...

Full description

Saved in:
Bibliographic Details
Published inClinical ophthalmology (Auckland, N.Z.) Vol. 9; no. default; pp. 1373 - 1378
Main Authors Naito, Tomoko, Yoshikawa, Keiji, Mizoue, Shiro, Nanno, Mami, Kimura, Tairo, Suzumura, Hirotaka, Shiraga, Fumio
Format Journal Article
LanguageEnglish
Published New Zealand Dove Medical Press Limited 01.01.2015
Taylor & Francis Ltd
Dove Press
Dove Medical Press
Subjects
Online AccessGet full text
ISSN1177-5483
1177-5467
1177-5483
DOI10.2147/OPTH.S86450

Cover

Loading…
Abstract To analyze the relationship between intraocular pressure (IOP) and the progression of visual field defects in Japanese primary open-angle glaucoma (POAG) and normal-tension glaucoma (NTG) patients. The subjects of the study were patients undergoing treatment for POAG or NTG who had performed visual field tests at least ten times with a Humphrey field analyzer (Swedish interactive thresholding algorithm standard, C30-2 program). The progression of visual field defects was defined by a significantly negative value of the mean deviation slope at the final visual field test during the follow-up period. The relationships between the progression of visual field defects and IOP, as well as other clinical factors, were retrospectively analyzed. A total of 156 eyes of 156 patients were included in the analysis. Significant progression of visual field defects was observed in 70 eyes of 70 patients (44.9%), while no significant progression was evident in 86 eyes of 86 patients (55.1%). The eyes with visual field defect progression had significantly lower baseline IOP (P<0.05), as well as significantly lower IOP reduction rate (P<0.01). The standard deviation of IOP values during follow-up was significantly greater in the eyes with visual field defect progression than in eyes without (P<0.05). Reducing IOP is thought to be useful for Japanese POAG or NTG patients to suppress the progression of visual field defects. In NTG, IOP management should take into account not only achieving the target IOP, but also minimizing the fluctuation of IOP during follow-up period.
AbstractList Purpose: To analyze the relationship between intraocular pressure (IOP) and the progression of visual field defects in Japanese primary open-angle glaucoma (POAG) and normal-tension glaucoma (NTG) patients. Patients and methods: The subjects of the study were patients undergoing treatment for POAG or NTG who had performed visual field tests at least ten times with a Humphrey field analyzer (Swedish interactive thresholding algorithm standard, C30-2 program). The progression of visual field defects was defined by a significantly negative value of the mean deviation slope at the final visual field test during the follow-up period. The relationships between the progression of visual field defects and IOP, as well as other clinical factors, were retrospectively analyzed. Results: A total of 156 eyes of 156 patients were included in the analysis. Significant progression of visual field defects was observed in 70 eyes of 70 patients (44.9%), while no significant progression was evident in 86 eyes of 86 patients (55.1%). The eyes with visual field defect progression had significantly lower baseline IOP (P<0.05), as well as significantly lower IOP reduction rate (P<0.01). The standard deviation of IOP values during follow-up was significantly greater in the eyes with visual field defect progression than in eyes without (P<0.05). Conclusion: Reducing IOP is thought to be useful for Japanese POAG or NTG patients to suppress the progression of visual field defects. In NTG, IOP management should take into account not only achieving the target IOP, but also minimizing the fluctuation of IOP during follow-up period. Keywords: primary open-angle glaucoma, normal-tension glaucoma, intraocular pressure, progression of visual field defects, MD slope
Tomoko Naito,1 Keiji Yoshikawa,2 Shiro Mizoue,3 Mami Nanno,4 Tairo Kimura,5 HirotakaSuzumura,6 Fumio Shiraga1 1Department of Ophthalmology, Okayama University Graduate School of Medicine, Okayama, Japan; 2Yoshikawa Eye Clinic, Tokyo, Japan; 3Department of Ophthalmology, Ehime University Graduate School ofMedicine, Ehime, Japan; 4Kagurazaka Minamino Eye Clinic, 5Ueno Eye Clinic, 6Suzumura Eye Clinic, Tokyo,Japan Purpose: To analyze the relationship between intraocular pressure (IOP) and the progression of visual field defects in Japanese primary open-angle glaucoma (POAG) and normal-tension glaucoma (NTG) patients.Patients and methods: The subjects of the study were patients undergoing treatment for POAG or NTG who had performed visual field tests at least ten times with a Humphrey field analyzer (Swedish interactive thresholding algorithm standard, C30-2 program). The progression of visual field defects was defined by a significantly negative value of the mean deviation slope at the final visual field test during the follow-up period. The relationships between the progression of visual field defects and IOP, as well as other clinical factors, were retrospectively analyzed.Results: A total of 156 eyes of 156 patients were included in the analysis. Significant progression of visual field defects was observed in 70 eyes of 70 patients (44.9%), while no significant progression was evident in 86 eyes of 86 patients (55.1%). The eyes with visual field defect progression had significantly lower baseline IOP (P<0.05), as well as significantly lower IOP reduction rate (P<0.01). The standard deviation of IOP values during follow-up was significantly greater in the eyes with visual field defect progression than in eyes without (P<0.05).Conclusion: Reducing IOP is thought to be useful for Japanese POAG or NTG patients to suppress the progression of visual field defects. In NTG, IOP management should take into account not only achieving the target IOP, but also minimizing the fluctuation of IOP during follow-up period. Keywords: primary open-angle glaucoma, normal-tension glaucoma, intraocular pressure, progression of visual field defects, MD slope
To analyze the relationship between intraocular pressure (IOP) and the progression of visual field defects in Japanese primary open-angle glaucoma (POAG) and normal-tension glaucoma (NTG) patients.Patients and methods: The subjects of the study were patients undergoing treatment for POAG or NTG who had performed visual field tests at least ten times with a Humphrey field analyzer (Swedish interactive thresholding algorithm standard, C30-2 program). The progression of visual field defects was defined by a significantly negative value of the mean deviation slope at the final visual field test during the follow-up period. The relationships between the progression of visual field defects and IOP, as well as other clinical factors, were retrospectively analyzed.Results: A total of 156 eyes of 156 patients were included in the analysis. Significant progression of visual field defects was observed in 70 eyes of 70 patients (44.9%), while no significant progression was evident in 86 eyes of 86 patients (55.1%). The eyes with visual field defect progression had significantly lower baseline IOP (P<0.05), as well as significantly lower IOP reduction rate (P<0.01). The standard deviation of IOP values during follow-up was significantly greater in the eyes with visual field defect progression than in eyes without (P<0.05).Conclusion: Reducing IOP is thought to be useful for Japanese POAG or NTG patients to suppress the progression of visual field defects. In NTG, IOP management should take into account not only achieving the target IOP, but also minimizing the fluctuation of IOP during follow-up period.
To analyze the relationship between intraocular pressure (IOP) and the progression of visual field defects in Japanese primary open-angle glaucoma (POAG) and normal-tension glaucoma (NTG) patients. The subjects of the study were patients undergoing treatment for POAG or NTG who had performed visual field tests at least ten times with a Humphrey field analyzer (Swedish interactive thresholding algorithm standard, C30-2 program). The progression of visual field defects was defined by a significantly negative value of the mean deviation slope at the final visual field test during the follow-up period. The relationships between the progression of visual field defects and IOP, as well as other clinical factors, were retrospectively analyzed. A total of 156 eyes of 156 patients were included in the analysis. Significant progression of visual field defects was observed in 70 eyes of 70 patients (44.9%), while no significant progression was evident in 86 eyes of 86 patients (55.1%). The eyes with visual field defect progression had significantly lower baseline IOP (P<0.05), as well as significantly lower IOP reduction rate (P<0.01). The standard deviation of IOP values during follow-up was significantly greater in the eyes with visual field defect progression than in eyes without (P<0.05). Reducing IOP is thought to be useful for Japanese POAG or NTG patients to suppress the progression of visual field defects. In NTG, IOP management should take into account not only achieving the target IOP, but also minimizing the fluctuation of IOP during follow-up period.
PURPOSETo analyze the relationship between intraocular pressure (IOP) and the progression of visual field defects in Japanese primary open-angle glaucoma (POAG) and normal-tension glaucoma (NTG) patients.PATIENTS AND METHODSThe subjects of the study were patients undergoing treatment for POAG or NTG who had performed visual field tests at least ten times with a Humphrey field analyzer (Swedish interactive thresholding algorithm standard, C30-2 program). The progression of visual field defects was defined by a significantly negative value of the mean deviation slope at the final visual field test during the follow-up period. The relationships between the progression of visual field defects and IOP, as well as other clinical factors, were retrospectively analyzed.RESULTSA total of 156 eyes of 156 patients were included in the analysis. Significant progression of visual field defects was observed in 70 eyes of 70 patients (44.9%), while no significant progression was evident in 86 eyes of 86 patients (55.1%). The eyes with visual field defect progression had significantly lower baseline IOP (P<0.05), as well as significantly lower IOP reduction rate (P<0.01). The standard deviation of IOP values during follow-up was significantly greater in the eyes with visual field defect progression than in eyes without (P<0.05).CONCLUSIONReducing IOP is thought to be useful for Japanese POAG or NTG patients to suppress the progression of visual field defects. In NTG, IOP management should take into account not only achieving the target IOP, but also minimizing the fluctuation of IOP during follow-up period.
Purpose: To analyze the relationship between intraocular pressure (IOP) and the progression of visual field defects in Japanese primary open-angle glaucoma (POAG) and normal-tension glaucoma (NTG) patients. Patients and methods: The subjects of the study were patients undergoing treatment for POAG or NTG who had performed visual field tests at least ten times with a Humphrey field analyzer (Swedish interactive thresholding algorithm standard, C30-2 program). The progression of visual field defects was defined by a significantly negative value of the mean deviation slope at the final visual field test during the follow-up period. The relationships between the progression of visual field defects and IOP, as well as other clinical factors, were retrospectively analyzed. Results: A total of 156 eyes of 156 patients were included in the analysis. Significant progression of visual field defects was observed in 70 eyes of 70 patients (44.9%), while no significant progression was evident in 86 eyes of 86 patients (55.1%). The eyes with visual field defect progression had significantly lower baseline IOP (P<0.05), as well as significantly lower IOP reduction rate (P<0.01). The standard deviation of IOP values during follow-up was significantly greater in the eyes with visual field defect progression than in eyes without (P<0.05). Conclusion: Reducing IOP is thought to be useful for Japanese POAG or NTG patients to suppress the progression of visual field defects. In NTG, IOP management should take into account not only achieving the target IOP, but also minimizing the fluctuation of IOP during follow-up period.
Audience Academic
Author Yoshikawa, Keiji
Suzumura, Hirotaka
Mizoue, Shiro
Kimura, Tairo
Shiraga, Fumio
Naito, Tomoko
Nanno, Mami
AuthorAffiliation 1 Department of Ophthalmology, Okayama University Graduate School of Medicine, Okayama, Japan
4 Kagurazaka Minamino Eye Clinic, Tokyo, Japan
5 Ueno Eye Clinic, Tokyo, Japan
6 Suzumura Eye Clinic, Tokyo, Japan
2 Yoshikawa Eye Clinic, Tokyo, Japan
3 Department of Ophthalmology, Ehime University Graduate School of Medicine, Ehime, Japan
AuthorAffiliation_xml – name: 1 Department of Ophthalmology, Okayama University Graduate School of Medicine, Okayama, Japan
– name: 6 Suzumura Eye Clinic, Tokyo, Japan
– name: 4 Kagurazaka Minamino Eye Clinic, Tokyo, Japan
– name: 3 Department of Ophthalmology, Ehime University Graduate School of Medicine, Ehime, Japan
– name: 2 Yoshikawa Eye Clinic, Tokyo, Japan
– name: 5 Ueno Eye Clinic, Tokyo, Japan
Author_xml – sequence: 1
  givenname: Tomoko
  surname: Naito
  fullname: Naito, Tomoko
– sequence: 2
  givenname: Keiji
  surname: Yoshikawa
  fullname: Yoshikawa, Keiji
– sequence: 3
  givenname: Shiro
  surname: Mizoue
  fullname: Mizoue, Shiro
– sequence: 4
  givenname: Mami
  surname: Nanno
  fullname: Nanno, Mami
– sequence: 5
  givenname: Tairo
  surname: Kimura
  fullname: Kimura, Tairo
– sequence: 6
  givenname: Hirotaka
  surname: Suzumura
  fullname: Suzumura, Hirotaka
– sequence: 7
  givenname: Fumio
  surname: Shiraga
  fullname: Shiraga, Fumio
BackLink https://www.ncbi.nlm.nih.gov/pubmed/26229431$$D View this record in MEDLINE/PubMed
BookMark eNptkttrFDEUxgep2Is--S4Dggiya-4z81IoRW2hUNH6HDLJyWyW7GRNZlb8783e6m4peUg4-Z0vJx_feXHShx6K4i1GU4JZ9fn--8PN9GctGEcvijOMq2rCWU1PDs6nxXlKc4QEQXX1qjglgpCGUXxWhB_g1eBCn2ZuWbYw_AHoy2UMXYSUcr0Mtly5NCpfWgfelAYs6KFUvSldP0QV9OhVzC2ZHyPkYj67hYp_y7CEfqL6zkPZeTXqsFCvi5dW-QRvdvtF8evrl4frm8nd_bfb66u7iRY1GibCKF3VgoAgRllsDK84RUY0DYYWcyMUWMZrQjkV2IgKaYUro2mjW0uMqelFcbvVNUHN5W4gGZSTm0KInVRxcNqDrOsWNy3GiCrBiG0VAcivKmGpoDVustblVms5tgswGtbf9keixze9m8kurCTjWOBKZAG0H2YFG6OeTLSvZockIRVft3zcvRnD7xHSIBcuafBe9RDGJHGFMGWMbdTfP0HnYYx9djdrEU5JnU36T3Uq_9n1NuRR9VpUXjHGKyoEZ5maPkPlZWDhdM6ddbl-1PDhoGEGyg-zFPy4idQx-O7QxEcD9lHMwKctoGNIKYJ9RDCS66DLddDlNuiZxk9o7YZNkPPAzj_b8w9FtgFN
CitedBy_id crossref_primary_10_1111_ceo_13372
crossref_primary_10_1136_bmjopen_2017_019416
crossref_primary_10_1371_journal_pone_0164876
crossref_primary_10_1007_s12325_017_0552_5
crossref_primary_10_1111_jcpt_12468
crossref_primary_10_1038_s41598_021_87844_1
crossref_primary_10_1167_iovs_18_24635
crossref_primary_10_1007_s00347_018_0658_4
crossref_primary_10_1155_2017_1480746
crossref_primary_10_1007_s12325_016_0297_6
ContentType Journal Article
Copyright COPYRIGHT 2015 Dove Medical Press Limited
2015. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
2015 Naito et al. This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution – Non Commercial (unported, v3.0) License 2015
Copyright_xml – notice: COPYRIGHT 2015 Dove Medical Press Limited
– notice: 2015. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: 2015 Naito et al. This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution – Non Commercial (unported, v3.0) License 2015
DBID AAYXX
CITATION
NPM
3V.
7X7
7XB
8AO
8FI
8FJ
8FK
8G5
ABUWG
AFKRA
AZQEC
BENPR
CCPQU
DWQXO
FYUFA
GHDGH
GNUQQ
GUQSH
K9.
M0S
M2O
MBDVC
PHGZM
PHGZT
PIMPY
PKEHL
PQEST
PQQKQ
PQUKI
PRINS
Q9U
7X8
5PM
DOA
DOI 10.2147/OPTH.S86450
DatabaseName CrossRef
PubMed
ProQuest Central (Corporate)
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
ProQuest Pharma Collection
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Research Library
ProQuest Central
ProQuest Central UK/Ireland
ProQuest Central Essentials
ProQuest Central
ProQuest One
ProQuest Central Korea
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
ProQuest Research Library
ProQuest Health & Medical Complete (Alumni)
ProQuest Health & Medical Collection
Research Library
Research Library (Corporate)
ProQuest Central Premium
ProQuest One Academic (New)
ProQuest Publicly Available Content Database
ProQuest One Academic Middle East (New)
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
ProQuest Central Basic
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
PubMed
Publicly Available Content Database
Research Library Prep
ProQuest Central Student
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
Research Library (Alumni Edition)
ProQuest Pharma Collection
ProQuest Central China
ProQuest Central
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
ProQuest Research Library
ProQuest Central (New)
ProQuest Central Basic
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Hospital Collection (Alumni)
ProQuest Health & Medical Complete
ProQuest One Academic UKI Edition
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList



PubMed
MEDLINE - Academic
Publicly Available Content Database
Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: BENPR
  name: ProQuest Central Database Suite (ProQuest)
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1177-5483
EndPage 1378
ExternalDocumentID oai_doaj_org_article_88b19b1103a642fba2ee2daa6f363819
PMC4516176
oai_dovepress_com_22756
A445736654
26229431
10_2147_OPTH_S86450
Genre Journal Article
GeographicLocations Blue Mountains
United States--US
Japan
GeographicLocations_xml – name: United States--US
– name: Blue Mountains
– name: Japan
GroupedDBID ---
0YH
29B
2WC
53G
5VS
6J9
7X7
8AO
8FI
8FJ
8G5
AAYXX
ABDBF
ABUWG
ACGFO
ACUHS
ADBBV
ADRAZ
AFKRA
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AOIJS
AZQEC
BAWUL
BCNDV
BENPR
BPHCQ
BVXVI
C1A
CCPQU
CITATION
DIK
DWQXO
E3Z
EBD
EBS
EJD
F5P
FRP
FYUFA
GNUQQ
GROUPED_DOAJ
GUQSH
GX1
HMCUK
HYE
IAO
IHR
IHW
ITC
KQ8
M2O
M48
O5R
O5S
OK1
P2P
PGMZT
PHGZM
PHGZT
PIMPY
PQQKQ
PROAC
RNS
RPM
TDBHL
TR2
UKHRP
VDV
W2D
NPM
PMFND
3V.
7XB
8FK
K9.
MBDVC
PKEHL
PQEST
PQUKI
PRINS
Q9U
7X8
PUEGO
-
ADACO
BBAFP
LI0
M~E
5PM
ID FETCH-LOGICAL-c680t-6dac7862e62daf1dd57530d6991eb15d6aef458235361d670ca17dc39cbf2dd83
IEDL.DBID M48
ISSN 1177-5483
1177-5467
IngestDate Wed Aug 27 01:30:06 EDT 2025
Thu Aug 21 14:13:20 EDT 2025
Mon Jan 18 10:57:23 EST 2021
Fri Sep 05 09:08:05 EDT 2025
Mon Jun 30 06:30:43 EDT 2025
Tue Jun 17 21:32:36 EDT 2025
Tue Jun 10 20:21:59 EDT 2025
Thu May 22 21:12:46 EDT 2025
Mon Jul 21 06:02:00 EDT 2025
Thu Apr 24 23:12:54 EDT 2025
Tue Jul 01 02:21:33 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue default
Keywords normal-tension glaucoma
progression of visual field defects
intraocular pressure
primary open-angle glaucoma
MD slope
Language English
License http://creativecommons.org/licenses/by-nc/3.0
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c680t-6dac7862e62daf1dd57530d6991eb15d6aef458235361d670ca17dc39cbf2dd83
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
OpenAccessLink http://journals.scholarsportal.info/openUrl.xqy?doi=10.2147/opth.s86450
PMID 26229431
PQID 2225328536
PQPubID 3933183
PageCount 6
ParticipantIDs doaj_primary_oai_doaj_org_article_88b19b1103a642fba2ee2daa6f363819
pubmedcentral_primary_oai_pubmedcentral_nih_gov_4516176
dovepress_primary_oai_dovepress_com_22756
proquest_miscellaneous_1701344476
proquest_journals_2225328536
gale_infotracmisc_A445736654
gale_infotracacademiconefile_A445736654
gale_healthsolutions_A445736654
pubmed_primary_26229431
crossref_primary_10_2147_OPTH_S86450
crossref_citationtrail_10_2147_OPTH_S86450
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2015-01-01
PublicationDateYYYYMMDD 2015-01-01
PublicationDate_xml – month: 01
  year: 2015
  text: 2015-01-01
  day: 01
PublicationDecade 2010
PublicationPlace New Zealand
PublicationPlace_xml – name: New Zealand
– name: Auckland
PublicationTitle Clinical ophthalmology (Auckland, N.Z.)
PublicationTitleAlternate Clin Ophthalmol
PublicationYear 2015
Publisher Dove Medical Press Limited
Taylor & Francis Ltd
Dove Press
Dove Medical Press
Publisher_xml – name: Dove Medical Press Limited
– name: Taylor & Francis Ltd
– name: Dove Press
– name: Dove Medical Press
References 1168023 - Am J Ophthalmol. 1975 Apr;79(4):557-66
17698763 - Arch Ophthalmol. 2007 Aug;125(8):1124-5
12523884 - Arch Ophthalmol. 2003 Jan;121(1):48-56
19492005 - Can J Ophthalmol. 2009;44 Suppl 1:S7-93
11447046 - Am J Epidemiol. 2001 Jul 15;154(2):138-44
12049574 - Arch Ophthalmol. 2002 Jun;120(6):701-13; discussion 829-30
21600658 - Ophthalmology. 2011 Sep;118(9):1766-73
15350316 - Ophthalmology. 2004 Sep;111(9):1641-8
10844054 - Am J Ophthalmol. 2000 May;129(5):623-8
9780093 - Am J Ophthalmol. 1998 Oct;126(4):487-97
17936908 - Ophthalmology. 2008 Jun;115(6):934-40
9780094 - Am J Ophthalmol. 1998 Oct;126(4):498-505
22352070 - Nippon Ganka Gakkai Zasshi. 2012 Jan;116(1):3-46
7081360 - Am J Ophthalmol. 1982 May;93(5):622-8
22551324 - Acta Ophthalmol. 2012 Aug;90(5):e337-43
19668554 - Clin Ophthalmol. 2009;3:117-22
14716185 - Menopause. 2004 Jan-Feb;11(1):69-77
11024415 - Am J Ophthalmol. 2000 Oct;130(4):429-40
2023748 - Ophthalmology. 1991 Mar;98(3):296-300
14609824 - Br J Ophthalmol. 2003 Nov;87(11):1324-8
18082889 - Ophthalmology. 2008 Jul;115(7):1123-1129.e3
1687295 - Trans Am Ophthalmol Soc. 1991;89:757-90
5437825 - Am J Ophthalmol. 1970 Apr;69(4):608-10
8058289 - Ophthalmology. 1994 Aug;101(8):1440-4
18695095 - Arch Ophthalmol. 2008 Aug;126(8):1030-6
15745761 - Ophthalmology. 2005 Mar;112(3):366-75
3390051 - Arch Ophthalmol. 1988 Jul;106(7):898-900
15037889 - Eye (Lond). 2004 Oct;18(10):984-9
16111758 - Ophthalmology. 2005 Oct;112(10):1661-9
9097306 - Ophthalmologica. 1997;211(2):66-71
11384564 - Am J Ophthalmol. 2001 Jun;131(6):699-708
12365904 - Arch Ophthalmol. 2002 Oct;120(10):1268-79
References_xml – reference: 22551324 - Acta Ophthalmol. 2012 Aug;90(5):e337-43
– reference: 16111758 - Ophthalmology. 2005 Oct;112(10):1661-9
– reference: 15037889 - Eye (Lond). 2004 Oct;18(10):984-9
– reference: 12049574 - Arch Ophthalmol. 2002 Jun;120(6):701-13; discussion 829-30
– reference: 12523884 - Arch Ophthalmol. 2003 Jan;121(1):48-56
– reference: 11384564 - Am J Ophthalmol. 2001 Jun;131(6):699-708
– reference: 1687295 - Trans Am Ophthalmol Soc. 1991;89:757-90
– reference: 2023748 - Ophthalmology. 1991 Mar;98(3):296-300
– reference: 9780094 - Am J Ophthalmol. 1998 Oct;126(4):498-505
– reference: 10844054 - Am J Ophthalmol. 2000 May;129(5):623-8
– reference: 22352070 - Nippon Ganka Gakkai Zasshi. 2012 Jan;116(1):3-46
– reference: 1168023 - Am J Ophthalmol. 1975 Apr;79(4):557-66
– reference: 5437825 - Am J Ophthalmol. 1970 Apr;69(4):608-10
– reference: 11024415 - Am J Ophthalmol. 2000 Oct;130(4):429-40
– reference: 15350316 - Ophthalmology. 2004 Sep;111(9):1641-8
– reference: 18082889 - Ophthalmology. 2008 Jul;115(7):1123-1129.e3
– reference: 19668554 - Clin Ophthalmol. 2009;3:117-22
– reference: 9097306 - Ophthalmologica. 1997;211(2):66-71
– reference: 3390051 - Arch Ophthalmol. 1988 Jul;106(7):898-900
– reference: 19492005 - Can J Ophthalmol. 2009;44 Suppl 1:S7-93
– reference: 9780093 - Am J Ophthalmol. 1998 Oct;126(4):487-97
– reference: 18695095 - Arch Ophthalmol. 2008 Aug;126(8):1030-6
– reference: 17936908 - Ophthalmology. 2008 Jun;115(6):934-40
– reference: 15745761 - Ophthalmology. 2005 Mar;112(3):366-75
– reference: 12365904 - Arch Ophthalmol. 2002 Oct;120(10):1268-79
– reference: 21600658 - Ophthalmology. 2011 Sep;118(9):1766-73
– reference: 14716185 - Menopause. 2004 Jan-Feb;11(1):69-77
– reference: 11447046 - Am J Epidemiol. 2001 Jul 15;154(2):138-44
– reference: 8058289 - Ophthalmology. 1994 Aug;101(8):1440-4
– reference: 17698763 - Arch Ophthalmol. 2007 Aug;125(8):1124-5
– reference: 14609824 - Br J Ophthalmol. 2003 Nov;87(11):1324-8
– reference: 7081360 - Am J Ophthalmol. 1982 May;93(5):622-8
SSID ssj0062087
Score 2.1012998
Snippet To analyze the relationship between intraocular pressure (IOP) and the progression of visual field defects in Japanese primary open-angle glaucoma (POAG) and...
Purpose: To analyze the relationship between intraocular pressure (IOP) and the progression of visual field defects in Japanese primary open-angle glaucoma...
PURPOSETo analyze the relationship between intraocular pressure (IOP) and the progression of visual field defects in Japanese primary open-angle glaucoma...
Tomoko Naito,1 Keiji Yoshikawa,2 Shiro Mizoue,3 Mami Nanno,4 Tairo Kimura,5 HirotakaSuzumura,6 Fumio Shiraga1 1Department of Ophthalmology, Okayama University...
SourceID doaj
pubmedcentral
dovepress
proquest
gale
pubmed
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage 1373
SubjectTerms Analysis
Care and treatment
Collaboration
Comparative analysis
Defects
Development and progression
Field study
Glaucoma
Hypertension
Intraocular pressure
MD slope
Measurement
Myopia
normal-tension glaucoma
Open-angle glaucoma
Original Research
primary open-angle glaucoma
progression of visual field defects
Standard deviation
Visual acuity
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1La9wwEBYlhz4Ope-6SVsVAqUFU1uSJe0xLQ1LoQ9oArkJyZKThWCX7Dq_PzOS1qzbQi-9GWnWtmZG81h_miHkMCjHOHjSUtqalaLufOl0AxvPVt62fOGCjQDZb3J5Kr6cNWc7rb4QE5bKAyfGfdDa1QsHTopbCJU7Z1kIzFsrOy4x20DrCz5vm0wlGyxZpXNbFVVCTM7TyTzsyQO56Ab0R0uBR-13fFEs2X-P3PHDdcKg_mmkd7zUHEG545KOH5D7OZakR2kND8mt0D8it7_mr-WPyTAh3S5Wv2hGZNGIyErVOOjQ0evVeoSbRCQb9QHRHdT2nq7wkUNEqdL4ouNVgEG4juUpKLbdKm1_fhkoROAjKK59Qk6PP598Wpa5wULZSl1tSgniUJDSBAkc7WrvIXbjlZcQM4IJb7y0ocPvarzhsvZSVa2tlQcJtq5j3mv-lOz1Qx-eE1oJ1alFsHVlIePUVkvpNK-DgohEu04U5P2W1abN1cexCcalgSwE5WK-_zhZmp9RLgU5nIjzqv5O9hFlNpFgpew4APpjsv6Yf-lPQd5NEv_tTttR4KBhWCa_IK9RI0w6ojrZBnMkRKM49nEuyNtIgdYBltfafMgBmIR1tmaUBzNK2NXtfHqrdSZblbXB3JwzCLDgTd5M0_hLRMr1YRjXBuvrcyGEAppnSUmnZTHJ2AIixoKomfrO1j2f6VcXseY49nOulXzxP1i-T-5C2NmkP7IOyN7magwvIbTbuFdxF98A7N1ONQ
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: ProQuest Central
  dbid: BENPR
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3db9MwELegk_h4QHwTGGCkSQikbInt2O4T2tCmCokxwSbtzXJiZ6s0JaNt9vdz57ihAcRbZV_S2PfhO_vnO0J2vCoZh5U0lTZnqchrl5a6AMWzmbMVn5beBoDssZydiS_nxXnccFtGWOXaJgZD7doK98j3MC7hDBYX-en6Z4pVo_B0NZbQuE22wATrYkK2Dg6PT76vbbFkmY7lVVRagE3ob-hhbZ69byens90fWgq8cr-xJoXU_ffJXdfe9FjUv431xmo1RlJuLE1HD8mD6FPS_V4IHpFbvnlM7nyNp-ZPSDsg3i7n1zQis2hAZvVZOWhb05v5soOXBEQbdR5RHtQ2js7xL9uAVqXhQ7uFh0b4HdJUUCy_ldrm4spT8MQ7mEz7lJwdHZ5-nqWx0EJaSZ2tUglsURDaeMmcrXPnwIfjmZPgO4IpL5y0vsbzNQ6znzupssrmygEnq7Jmzmn-jEyatvEvCM2EqtXU2zyzEHlqq6UsNc-9As9El7VIyMf1VJsqZiHHYhhXBqIR5ItBvpieLwnZGYjjqP5NdoA8G0gwY3ZoaBcXJiqg0brMpyU4O9xCyFWXlnkPo7Wy5hKj1oR8GDj-x5vWrTCDhmG6_IS8RYkw_VXVwUaYfSEKxbGec0LeBwq0EjC8ysbLDjBJmG9rRLk9ogTtrsbda6kz0boszW9dSMi7oRufRMRc49tuaTDPPhdCKKB53gvpMCwmGZuC55gQNRLf0bjHPc38MuQex7rOuZIv__9Zr8g9cCyLfqtqm0xWi86_BudtVb6JGvoLNc1GcA
  priority: 102
  providerName: ProQuest
Title Relationship between progression of visual field defect and intraocular pressure in primary open-angle glaucoma
URI https://www.ncbi.nlm.nih.gov/pubmed/26229431
https://www.proquest.com/docview/2225328536
https://www.proquest.com/docview/1701344476
http://www.dovepress.com/getfile.php?fileID=26094
https://pubmed.ncbi.nlm.nih.gov/PMC4516176
https://doaj.org/article/88b19b1103a642fba2ee2daa6f363819
Volume 9
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3raxQxEA-1BR8fxLer9YxQEIWV3SSb5D6ItNJyCK1Fe3B-CtlNtj04dvUeRf97Z7IPurUf_XIcyewj80hmNr_MELLnVc44rKSxtCmLRVq6ONcZGJ5NnC34OPc2AGRP5GQqvsyy2RbpinG2DFzdGNphPanpcvHh968_n8DgPyKMORUK2tegEVoKjN13YEmSqN7Hot9OkCzRbZUVFYOLzpuDetcvHixNIYP_PXLH1ZcNJPXfOfvKojUEVF5ZoY4ekPuta0n3G114SLZ89YjcPm43zx-Tuge-Xcx_0hagRQNAq0nOQeuSXs5XG7hJALZR5xHsQW3l6BwfWQfQKg0vull6aIT_IVsFRa7FtjpfeAoO-Qb02D4h06PDs8-TuK23EBdSJ-tYgnQURDheMmfL1Dlw5XjiJLiQMKNnTlpf4jYbz7hMnVRJYVPlQKBFXjLnNH9Ktqu68s8JTYQq1djbNLEQgGqrpcw1T70CB0XnpYjI-47VpmiTkWNNjIWBoATlYr6enk3M9yCXiOz1xO2obiY7QJn1JJg4OzTUy3PT2qHROk_HOfg83ELkVeaWeQ-jtbLkEoPXiLzrJX7tTl0rcNAwzJofkdeoEaY5sdpPFWZfiExxLOsckbeBAtUXhlfY9swDMAnTbg0odweUYOTFsLvTOtPZiMFQnTPwt-BN3vTdeCUC5ypfb1YG0-1zIYQCmmeNkvbDYpKxMTiQEVED9R2Me9hTzS9CCnIs75wq-eJ_sPwluQteaNZ819ol2-vlxr8CT2-dj8it5McEftVMjcjOweHJ6bdR-GoyCvb9F4K6WeI
linkProvider Scholars Portal
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Zb9QwEB6VIlF4QNwECjVSEaJSaOIkdvYBoXJUW3qAxFbaN-PETrtSlZQ9ivhT_EZmnIMNIN76tnJmHdszniP-PAOwaWXGI7SkvtAh9-OwMH6WJrjxdGB0Hg0yqx1A9kgMj-OP42S8Aj_buzAEq2x1olPUpsrpG_k2xSURR-Mi3px_86lqFJ2utiU0arHYtz--Y8g2e733Hvn7nPPdD6N3Q7-pKuDnIg3mvsAxSPTjreBGF6Ex6LBEgRHoKKHeSozQtqDDpAhfFRohg1yH0uCw86zgxqQR9nsFrqLhDShXvxx3AZ7gQdoUc5F-ghqovg9IlYC2P30eDV99SUVMF_yXLKArFHAD1kx1USNf_zYNS7axj9tcMoS7t-Bm48GynVrkbsOKLe_AtcPmjP4uVB2-7nRyzhocGHM4sDoHCKsKdjGZLbATh59jxhKmhOnSsAm9snLYWOYGuphabMTfLikGo2Jfvi5PzixDv3-BrNP34PhSGHAfVsuqtA-BBbEs5MDqMNAY56Y6FSJLo9BK9IPSrIg92GqXWuVNznMqvXGmMPYhvijii6r54sFmR9zM6t9kb4lnHQnl53YN1fRENdtdpWkWDjJ0rSKNAV6RaW4tzlaLIhIUI3vwsuP4Hz21rbiCilNyfg82SCJUfTG200hqJ44TGVH1aA9eOArSSTi9XDdXK3CRKLtXj3K9R4m6JO8_bqVONbpspn7vPA-edY_pn4TPK221mCnK6h_FcSyR5kEtpN20uOB8gNvFA9kT3968-0_KyanLdE5VpEMpHv1_WBuwNhwdHqiDvaP9x3AdXdqk_ki2Dqvz6cI-Qbdxnj11e5XB18tWDr8AABKCfw
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwELbKVipwQLwJFGqkIgRS2MRJbO8BoZZ2taWwVLSVejNO7LQrVUnZRxF_jV_HTOKEDSBuva2cWcfjsecRf54hZNOKlEVgSX2uQ-bHYW78VCaw8XRgdBYNUqsrgOyYj47jDyfJyQr52dyFQVhloxMrRW3KDL-R9zEuiRgYF97PHSziYGf47uKbjxWk8KS1KadRL5F9--M7hG-zt3s7IOsXjA13j96PfFdhwM-4DOY-h_EI8OktZ0bnoTHgvESB4eA0gQ5LDNc2x4OlCF4bGi6CTIfCAAtZmjNjZAT9XiOrAqyi7JHV7d3xwZfGDnAWSFfaRfgJ6KP6diDWBep_PjgavTmUPMbr_kv2sCobcJNcN-VljYP921AsWcouinPJLA5vk1vOn6Vb9QK8Q1ZscZesfXIn9vdI2aLtziYX1KHCaIUKqzOC0DKnl5PZAjqp0HTUWESYUF0YOsFXlhVSllYDXUwtNMLvKkUGxdJfvi5Ozy2FKGABgtT3yfGViOAB6RVlYR8RGsQiFwOrw0BD1Cu15DyVUWgFeEUyzWOPvG6mWmUuAzoW4jhXEAmhXBTKRdVy8chmS-y4-jfZNsqsJcFs3VVDOT1VbvMrKdNwkIKjFWkI9_JUM2uBW83ziGPE7JFXrcT_6KlphRlUDFP1e2QDV4Sqr8m2-kltxXEiIqwl7ZGXFQVqKGAv0-6iBUwS5vrqUK53KEGzZN3HzapTTrPN1O996JHn7WP8J6L1ClsuZgpz_EdxHAugeVgv0pYtxhkbgNfqEdFZvh2-u0-KyVmV9xxrSoeCP_7_sDbIGigG9XFvvP-E3AD_Nqm_mK2T3ny6sE_Bh5ynz9xmpeTrVeuHX6faiCM
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Relationship+between+progression+of+visual+field+defect+and+intraocular+pressure+in+primary+open-angle+glaucoma&rft.jtitle=Clinical+ophthalmology+%28Auckland%2C+N.Z.%29&rft.au=Naito+T&rft.au=Yoshikawa+K&rft.au=Mizoue+S&rft.au=Nanno+M&rft.date=2015-01-01&rft.pub=Dove+Medical+Press&rft.issn=1177-5483&rft.volume=2015&rft.issue=default&rft.spage=1373&rft.epage=1378&rft_id=info:doi/10.2147%2Fopth.s86450&rft.externalDBID=DOA&rft.externalDocID=oai_doaj_org_article_88b19b1103a642fba2ee2daa6f363819
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1177-5483&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1177-5483&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1177-5483&client=summon